Lexitas https://validator.w3.org/feed/docs/rss2.html About Our Team For Sponsors Reading Center Finding Quality Clinical Research Sites Clinical Trials at the Summit Resources The Future Of Decentralized Clinical Trials In Ophthalmology Inside Look Podcast Series Careers Why Expertise in Ophthalmic Clinical Trials Matters for Medical and Protocol Writing  Lexitas Pharma Services Welcomes Dr. David Tanzer as Chief Medical Officer Lexitas CEO Jeanne Hecht On Trends And Challenges In Ophthalmology Clinical Trials Contact For Sites Choosing a CRO – Avoiding the Trap of Commoditization One Size Fits None – Internal Focus at the Expense of Customer Relationships All Under One Roof The Hidden Value of Onsite Monitoring Lexitas Monitors – Focused on Details and the Big Picture AI Helps Identify Patients Likely to Respond to Treatment During Ophthalmology Clinical Trials How Diversity, Equity and Inclusion in Clinical Trials Leads to Better Health Outcomes Improving Patient Retention in Ophthalmology Clinical Trials Speeding Ophthalmic Trial Execution with an In-House Reading Center Amber Ophthalmics Benefits From Image Reading Center To Develop New Treatment Options For PCED Inside Look: Lexitas’ Best Corrected Visual Acuity Certification Program Inside Look: Enrollment Rates in Ophthalmic Clinical Trials J.P. Morgan Takeaways with Jeanne Hecht Inside Look: Patient Retention in Ophthalmic Clinical Trials Building and Sustaining a Strong Company Culture Five Key Considerations When Selecting an Ophthalmology CRO Achieving Repeatability in Staining with a Modified NEI Scale Operationalizing an Ophthalmology Protocol Development In Virtual Reality Testing As A Standardized Clinical End Point (via Modern Retina) A Deeper Look at Pegcetacoplan (via Optometry Times Journal) The State of the Ophthalmology Funding Landscape Using AI in the Development of New Ophthalmic Treatment Trends in Ophthalmology Clinical Trials (Video) What The Best Ophthalmology Sponsors Do Differently? Best-Corrected Visual Acuity Testing In Clinical Practice and Clinical Trials Shawn Scranton, PharmD., on Revolutionizing the Treatment of Ophthalmic Diseases Lanita Scott, M.D. – Maximizing the Likelihood of Success for Your Ophthalmology Clinical Trials How Allgenesis Evaluated Unique Endpoints to Advance its Phase How Exonate Plans to Revolutionize Diabetic Eye Disease Treatment: A Convo with Dr. Catherine Beech The Impact of Contact Lens Wear On the Ocular Surface w/ Dr. Joe Shovlin From Patient Care to Research: Dr. Bruce Segal’s Journey with Ophthalmic Drug Approval Lifestyle Impact On Ocular Health w/ Dr. Sheetal Shah Home Advisory Board Board of Directors